Sign In
Buy TEM
$50.56
-1.76 (-3.36%)
At Close: Jun 16, 2026
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the publication of a study in JCO Precision Onco
Tempus AI, Inc. (TEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
04:25pm, Monday, 08'th Sep 2025
Tempus AI, Inc. (NASDAQ:TEM ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 1:05 PM EDT Company Participants Eric Lefkofsky - Co-Founder, CEO, President & Chairman James Ro
Tempus AI: Expansive Opportunity As Healthcare Becomes More Heavily Scrutinized
02:33pm, Thursday, 04'th Sep 2025
Tempus AI, Inc. is positioned for growth as U.S. pharmaceutical reshoring and regulatory scrutiny increase demand for data-driven healthcare services. Genomics and Data Services segments are experienc
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?
01:31pm, Thursday, 04'th Sep 2025
TEM's Q2 net loss narrows sharply, driven by surging genomics revenues, higher gross profits and tighter cost controls.
Northwestern Medicine Becomes First Health System to Integrate Tempus' Generative AI Co-Pilot, David, Into Its EHR Platform
08:30am, Thursday, 04'th Sep 2025
CHICAGO--(BUSINESS WIRE)--Northwestern Medicine and Tempus AI, Inc. (NASDAQ: TEM) today announced a notable expansion of their longstanding collaboration. Northwestern Medicine will be the first healt
Tempus to Participate in Morgan Stanley's 23rd Annual Global Healthcare Conference
04:01pm, Wednesday, 03'rd Sep 2025
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in Morgan Stanley's 23rd Annua
Tempus AI Stock Required A Tempered Position
04:31pm, Friday, 29'th Aug 2025
When a stock moves a lot, how do you control your risk and keep losses small? Here's what we did with Tempus AI.
Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership
09:46am, Tuesday, 26'th Aug 2025
TEM accelerates its healthcare edge with Paige, Deep 6 AI, and Ambry Genetics acquisitions, expanding data, tech and clinical reach.
Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now?
04:00pm, Monday, 25'th Aug 2025
BFLY trades at distressed levels with analyst targets signaling sharp upside, while TEM's premium valuation tempers its appeal.
The Next Big Thing: 2 AI-Powered Healthcare Stocks Ready to Explode
04:00am, Saturday, 23'rd Aug 2025
It's certainly no secret that artificial intelligence (AI) has the potential to change, well, everything for most industries. It's already reshaped several sectors, in fact, and promises to reshape ev
Tempus Announces the Acquisition of Paige
09:20am, Friday, 22'nd Aug 2025
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acquisition of Paige, an AI company speciali
4 Medical Devices Behemoths to Buy Amid Extensive AI Applications
09:06am, Friday, 22'nd Aug 2025
AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.
5 High Short-Interest Stocks to Buy Before November
11:47am, Wednesday, 20'th Aug 2025
This is a look at five stocks to consider buying before November. No, there isn't a major election cycle, but these high short-interest names have bullish market fundamentals and are expected to repor
Strategic Partnerships Power Tempus AI's Healthcare Expansion
10:36am, Tuesday, 19'th Aug 2025
TEM deepens collaborations in oncology and neuroscience using its Lens and Next platforms to accelerate precision medicine.
Tempus AI: TEM Stock To $130?
09:24am, Monday, 18'th Aug 2025
Tempus AI (NASDAQ: TEM) has already posted a strong 2x gain since its IPO, rising from $37 to $74. Although it trades at a lofty 14x trailing revenue multiple, the company's solid growth trajectory an
